(R,R)-2,6-Bis(4-isopropyl-2-oxazolin-2-yl)pyridine>98.0%(GC)5g

4-((4-((4-Aminophenyl)sulfonyl)phenyl)amino)-4-oxobutanoic acid, 98%, 100mg

1-Bromo-5-chloro-3-fluoro-2-nitrobenzene, 95+%, 1g

2-(2-(Benzyloxy)ethoxy)ethanol, 98.0%, 1kg

3,3'-Dihydroxy-[1,1'-biphenyl]-4,4'-dicarboxylic acid, 97%, 1g

Guaifenesin, 95+%, 500g

lithium 5-(((S)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoate dihydrate, 95%, 100mg

1,3-Dibromo-2-(3-bromopropoxy)benzene, 98%, 250mg

2-(3-Biphenylyl)amino-9,9-diphenylfluorene>98.0%(HPLC)(N)5g

(2S,4R)-4-(3-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID, 95%, 250mg

(2-Iodo-ethyl)-carbamic acid benzyl ester, 97%, 10g

Ethenesulfonic acid [4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]amide, 98%, 1g

(E)-3-(2,3-DICHLORO-4-(4-FLUOROPHENYLTHIO)PHENYL)ACRYLIC ACID, 95.0%, 250mg